Experience and acceptability for HPV self-sampling among women in Jiangsu province, China: a cross-sectional survey
Knowledge, willingness, uptake and barriers of cervical cancer screening services among Chinese adult females: a national cross-sectional survey based on a large e-commerce platform
The impact of offering multiple cervical screening options to women whose screening was overdue in Dumfries and Galloway, Scotland
Feasibility of human papillomavirus self-sampling to combat COVID-19-related disruptions to cervical cancer screening: a cross sectional survey
Cervical cancer knowledge and barriers and facilitators to screening among women in two rural communities in Guatemala: a qualitative study
Worldwide use of HPV self-sampling for cervical cancer screening
Cervical Cancer Screening Postpandemic: Self-Sampling Opportunities to Accelerate the Elimination of Cervical Cancer
New STI stats reveal a move to at home testing
Direct-to-Consumer Sexually Transmitted Infection Testing Services: A Position Statement from the American Sexually Transmitted Diseases Association
Using a multimethod approach to develop implementation strategies for a cervical self-sampling program in Kenya
Improving Cervical Screening Through Multiplex Detection and Self-Sampling
Unmet clinical needs in cervical cancer screening
Importance of Cytopathologic Diagnosis in Early Cancer Diagnosis in Resource-Constrained Countries
Contributions of Liquid-Based (Papanicolaou) Cytology and Human Papillomavirus Testing in Cotesting for Detection of Cervical Cancer and Precancer in the United States
Performance of human papillomavirus testing on self-collected versus clinician-collected samples for the detection of cervical intraepithelial neoplasia of grade 2 or worse: a randomised, paired screen-positive, non-inferiority trial
Point-of-care test for cervical cancer in LMICs
Keratin-17 Promotes p27KIP1 Nuclear Export and Degradation and Offers Potential Prognostic Utility
Keratin 17 in premalignant and malignant squamous lesions of the cervix: proteomic discovery and immunohistochemical validation as a diagnostic and prognostic biomarker
OncoGenesis, Inc. Names Teresa Prego as New CEO/President
OncoGenesis: Upgrading the Cervical Cancer Screening Paradigm
Unmet clinical needs in cervical cancer screening
Stony Brook Enters Licensing Agreement with OncoGenesis for Use of Cancer Biomarker
FDA Panel Recommends Replacement for the Pap Test
Alternative to Pap Test is Approved by FDA
Are Pap smears on the Way Out?
Coverage of cervical cancer screening in 57 countries: low average levels and large inequalities
Have Current Global Methods in Cervical Screening Gone Far Enough? (pdf)
DownloadEuropean Cancer Organisation Publishes a Position Paper on Self Collection & HPV Screening in Europe (pdf)
DownloadASCCP-OncoGenesis iPap Performance Poster (pdf)
DownloadCervical cancer screening in the United States - Challenges and potential solutions for underscreened groups (Preventative Medicine 144 (2021) 106400 (pdf)
DownloadWe use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.